Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Daré Bioscience, Inc., a biopharmaceutical company, identifies, develops, and markets products for women's health in the United States. It develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health. The company offers XACIATO for the treatment of bacterial vaginosis in female patients 12 years of age and older. It is developing Ovaprene, a hormone-free, monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia on demand for the treatment of female sexual arousal disorder; DARE-HRT1 to treat moderate to-severe vasomotor symptoms in menopausal hormone therapy; DARE-VVA1 for the treatment of moderate-to-severe dyspareunia or pain during sexual intercourse; and DARE-CIN to treat cervical intraepithelial neoplasia and other human papillomavirus related pathologies. The company is also developing DARE-PDM1 for the treatment of primary dysmenorrhea; DARE-204 and DARE-214, an injectable formulations contraception of etonogestrel designed to provide contraception over 6-month and 12-month periods; DARE-FRT1, an intravaginal ring designed to deliver bio-identical progesterone for luteal phase support as part of an in vitro fertilization treatment plan; and DARE-PTB1 for the prevention of preterm birth. In addition, it is developing DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design that controlled contraceptive option; DARE-LBT, a novel hydrogel formulation for vaginal delivery of live biotherapeutics to support vaginal health; DARE-GML, a multi-target antimicrobial agent; DARE-RH1, a novel approach to non-hormonal contraception for men and women by targeting the CatSper ion channel; and DARE-PTB2 for the prevention and treatment of idiopathic preterm birth through inhibition of a stress response protein. Daré Bioscience, Inc. is headquartered in San Diego, California. more
Time Frame | DARE | Sector | S&P500 |
---|---|---|---|
1-Week Return | -1.18% | 0.31% | -1.26% |
1-Month Return | 5.03% | 0.6% | -4.16% |
3-Month Return | -5.38% | -9.44% | -0.46% |
6-Month Return | -1.18% | -5.15% | 3.58% |
1-Year Return | -14.09% | 0.33% | 22.47% |
3-Year Return | -83.23% | 4.53% | 25.13% |
5-Year Return | -79.68% | 35.98% | 77.7% |
10-Year Return | -99.66% | 100.72% | 190.12% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | - | - | 10.00M | 10.00M | 2.81M | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":28.08,"profit":true}] |
Cost of Revenue | 11.14K | 43.23K | 26.41K | 47.62K | 38.36K | [{"date":"2019-12-31","value":23.39,"profit":true},{"date":"2020-12-31","value":90.78,"profit":true},{"date":"2021-12-31","value":55.47,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":80.57,"profit":true}] |
Gross Profit | (11.14K) | (43.23K) | (26.41K) | 10.00M | 2.77M | [{"date":"2019-12-31","value":-0.11,"profit":false},{"date":"2020-12-31","value":-0.43,"profit":false},{"date":"2021-12-31","value":-0.26,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":27.7,"profit":true}] |
Gross Margin | (Infinity%) | (Infinity%) | (0.26%) | 100.00% | 98.63% | [{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":-0.26,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.63,"profit":true}] |
Operating Expenses | 14.34M | 27.40M | 39.07M | 41.39M | 33.61M | [{"date":"2019-12-31","value":34.66,"profit":true},{"date":"2020-12-31","value":66.21,"profit":true},{"date":"2021-12-31","value":94.4,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":81.21,"profit":true}] |
Operating Income | (14.34M) | (27.40M) | (39.07M) | (31.39M) | (30.84M) | [{"date":"2019-12-31","value":-1434488000,"profit":false},{"date":"2020-12-31","value":-2740225700,"profit":false},{"date":"2021-12-31","value":-3906851200,"profit":false},{"date":"2022-12-31","value":-3138548800,"profit":false},{"date":"2023-12-31","value":-3083988000,"profit":false}] |
Total Non-Operating Income/Expense | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Pre-Tax Income | (14.26M) | (27.40M) | (38.70M) | (30.95M) | (30.16M) | [{"date":"2019-12-31","value":-1426383000,"profit":false},{"date":"2020-12-31","value":-2740074300,"profit":false},{"date":"2021-12-31","value":-3869610500,"profit":false},{"date":"2022-12-31","value":-3094773800,"profit":false},{"date":"2023-12-31","value":-3016139100,"profit":false}] |
Income Taxes | (81.05K) | (163.07K) | (369.89K) | (437.75M) | (3.00) | [{"date":"2019-12-31","value":-8105000,"profit":false},{"date":"2020-12-31","value":-16307000,"profit":false},{"date":"2021-12-31","value":-36988700,"profit":false},{"date":"2022-12-31","value":-43775000000,"profit":false},{"date":"2023-12-31","value":-300,"profit":false}] |
Income After Taxes | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Income From Continuous Operations | (14.26M) | (27.40M) | (38.70M) | (30.95M) | (41.05M) | [{"date":"2019-12-31","value":-1426383000,"profit":false},{"date":"2020-12-31","value":-2740074300,"profit":false},{"date":"2021-12-31","value":-3869610500,"profit":false},{"date":"2022-12-31","value":-3094773800,"profit":false},{"date":"2023-12-31","value":-4104705200,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (14.26M) | (27.40M) | (38.33M) | 406.80M | (30.16M) | [{"date":"2019-12-31","value":-3.51,"profit":false},{"date":"2020-12-31","value":-6.74,"profit":false},{"date":"2021-12-31","value":-9.42,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-7.41,"profit":false}] |
EPS (Diluted) | (0.95) | (0.97) | (0.71) | (0.37) | (0.34) | [{"date":"2019-12-31","value":-95,"profit":false},{"date":"2020-12-31","value":-97,"profit":false},{"date":"2021-12-31","value":-71,"profit":false},{"date":"2022-12-31","value":-36.52,"profit":false},{"date":"2023-12-31","value":-34,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
DARE | |
---|---|
Cash Ratio | 0.85 |
Current Ratio | 1.14 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
DARE | |
---|---|
ROA (LTM) | -71.42% |
ROE (LTM) | -994.69% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
DARE | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 1.08 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -0.08 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
DARE | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 10.20 |
P/B | 10.75 |
Price/FCF | NM |
EV/R | 10.18 |
EV/Ebitda | NM |
PEG | NM |
Dare Bioscience Inc (DARE) share price today is $3.34
Yes, Indians can buy shares of Dare Bioscience Inc (DARE) on Vested. To buy Dare Bioscience Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in DARE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Dare Bioscience Inc (DARE) via the Vested app. You can start investing in Dare Bioscience Inc (DARE) with a minimum investment of $1.
You can invest in shares of Dare Bioscience Inc (DARE) via Vested in three simple steps:
The 52-week high price of Dare Bioscience Inc (DARE) is $7.56. The 52-week low price of Dare Bioscience Inc (DARE) is $2.67.
The price-to-earnings (P/E) ratio of Dare Bioscience Inc (DARE) is
The price-to-book (P/B) ratio of Dare Bioscience Inc (DARE) is 10.75
The dividend yield of Dare Bioscience Inc (DARE) is 0.00%
The market capitalization of Dare Bioscience Inc (DARE) is $29.06M
The stock symbol (or ticker) of Dare Bioscience Inc is DARE